MORGAN STANLEY PLC/CALL/MERCK & CO./170/0.1/17.01.25 Share Price

Warrant

DE000MB8B1N9

Real-time Bid/Ask 16:41:20 21/05/2024 BST
0.071 EUR / 0.075 EUR -2.67% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./170/0.1/17.01.25
Current month-20.21%
1 month-17.58%
Date Price Change
21/05/24 0.065 -13.33%
20/05/24 0.075 +8.70%
17/05/24 0.069 -8.00%
16/05/24 0.075 -7.41%
15/05/24 0.081 +15.71%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 07:37 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB8B1N
ISINDE000MB8B1N9
Date issued 04/07/2023
Strike 170 $
Maturity 17/01/2025 (241 Days)
Parity 10 : 1
Emission price 0.15
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.152
Lowest since issue 0.016
Delta0.08x
Omega 14.03
Premium30.2x
Gearing165.48x
Moneyness 0.7716
Difference Strike 38.67 $
Difference Strike %+22.75%
Spread 0.004
Spread %5.33%
Theoretical value 0.0710
Implied Volatility 20.33 %
Total Loss Probability 93.83 %
Intrinsic value 0.000000
Present value 0.0710
Break even 170.77 €
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus